Modelling the active SARS-CoV-2 helicase complex as a basis for structure-based inhibitor design
D. Berta, M. Badaoui, P. J. Buigues, S. A. Martino, A. Pisliakov, N. Elghobashi-Meinhardt, G. Wells, S. A. Harris, E. Frezza, E. Rosta
This study models the active SARS-CoV-2 helicase complex to provide structural insights for inhibitor design.
bioRxiv · Nov 3, 2020Biochemistry